Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 8 de 8
Filter
Add more filters










Database
Language
Publication year range
1.
Fundam Clin Pharmacol ; 38(1): 168-182, 2024 Feb.
Article in English | MEDLINE | ID: mdl-37558213

ABSTRACT

INTRODUCTION: Inflammation is a physiological event that protects the organism against different factors that lead to loss of tissue homeostasis. Dihydropyridine (DHP) derivatives are heterocyclic compounds known for their different biological activities, including anti-inflammatory activities. OBJECTIVE: To evaluate the anti-inflammatory activity of 1,4-dihydropyridine (1,4-DHP) derivatives using anti-inflammatory models in vitro, in RAW264.7 cells induced by lipopolysaccharide (LPS) and in vivo using the acute lung injury (ALI) model in mice. RESULTS: Fifteen compounds derived from 1,4-DHP were tested in RAW264.7 cells for their cytotoxic effect and cell viability. Thereafter, only the six compounds that showed the highest cell viability were tested for the production or inhibition of the pro-inflammatory cytokine interleukin 6 (IL-6). The best compound (compound 4) was tested for its anti-inflammatory effects in vitro and in vivo, showing inhibition of nitric oxide (NO), pro-inflammatory cytokines, increased phagocytic activity, and an increase in IL-10 in vitro. In in vivo tests, compound 4 also reduces the levels of NO, myeloperoxidase (MPO) activity, leukocyte migration, and exudation, as well as reducing the levels of tumor necrosis factor-alpha (TNF-α) and IL-6 and preventing the loss in the lung architecture. CONCLUSION: This compound showed important anti-inflammatory activity, with a significant ability to reduce the production of pro-inflammatory mediators and increase the phagocytic activity of macrophages and anti-inflammatory mediator secretion (IL-10). These findings led us to hypothesize that this compound can repolarize the macrophage response to an anti-inflammatory profile (M2). Moreover, it was also able to maintain its anti-inflammatory activity in vivo experiments.


Subject(s)
Dihydropyridines , Interleukin-10 , Interleukin-6 , Mice , Animals , Cytokines , Anti-Inflammatory Agents/pharmacology , Tumor Necrosis Factor-alpha , Lipopolysaccharides/pharmacology , Nitric Oxide
2.
Inflamm Res ; 71(7-8): 741-758, 2022 Aug.
Article in English | MEDLINE | ID: mdl-35612604

ABSTRACT

INTRODUCTION: Several experimental models have been designed to promote the development of new anti-inflammatory drugs. The in vitro model using RAW 264.7 cells has been widely used. However, there is still no consensus on which inflammatory mediators should initially be measured to screen for possible anti-inflammatory effects. To determine the rationality of measuring inflammatory mediators together with NO, such as the levels of tumor necrosis factor (TNF)-α, and interleukins (IL) 1ß and 6, we carried out this systematic review (SR) and meta-analysis (MA). METHODOLOGY: We conducted this SR and MA in accordance with the Preferred Reporting of Systematic Reviews and Meta-Analysis and the Cochrane Handbook for Systematic Reviews of Intervention. This review was registered in the Open Science Framework ( https://doi.org/10.17605/OSF.IO/8C3HT ). RESULTS: LPS-induced cells produced high NO levels compared to non-LPS induced, and this production was not related to cell density. TNF-α, IL-1ß, and IL-6, also showed high levels after cells had been stimulated with LPS. Though with some restrictions, all studies were reliable, as the risk of bias was detected in the test compounds and systems. CONCLUSION: Measurement of NO levels may be sufficient to screen for possible anti-inflammatory action in the context of LPS-induced RAW 264.7 cells.


Subject(s)
Lipopolysaccharides , Macrophages , Animals , Anti-Inflammatory Agents/pharmacology , Biomarkers , Inflammation Mediators , Interleukin-1beta/pharmacology , Lipopolysaccharides/pharmacology , Mice , NF-kappa B , Nitric Oxide , RAW 264.7 Cells , Tumor Necrosis Factor-alpha/pharmacology
3.
Mediators Inflamm ; 2020: 4620251, 2020.
Article in English | MEDLINE | ID: mdl-32410853

ABSTRACT

OBJECTIVE: The aim of this study was to investigate the anti-inflammatory effects of the crude extract (CE), derived fraction, and isolated compounds from Calea pinnatifida leaves in a mouse model of pulmonary neutrophilia. METHODS: The CE and derived fractions, hexane, ethyl acetate, and methanol, were obtained from C. pinnatifida leaves. The compounds 3,5- and 4,5-di-O-E-caffeoylquinic acids were isolated from the EtOAc fraction using chromatography and were identified using infrared spectroscopic data and nuclear magnetic resonance (1H and 13C NMR). Leukocytes count, protein concentration of the exudate, myeloperoxidase (MPO) and adenosine deaminase (ADA), and nitrate/nitrite (NO x ), tumor necrosis factor-alpha (TNF-α), interleukin-1-beta (IL-1ß), and interleukin-17A (IL-17A) levels were determined in the pleural fluid leakage after 4 h of pleurisy induction. We also analyzed the effects of isolated compounds on the phosphorylation of both p65 and p38 in the lung tissue. RESULTS: The CE, its fractions, and isolated compounds inhibited leukocyte activation, protein concentration of the exudate, and MPO, ADA, NO x , TNF-α, IL-1ß, and IL-17A levels. 3,5- and 4,5-di-O-E-caffeoylquinic acids also inhibited phosphorylation of both p65 and p38 (P < 0.05). CONCLUSION: This study demonstrated that C. pinnatifida presents important anti-inflammatory properties by inhibiting activated leukocytes and protein concentration of the exudate. These effects were related to the inhibition of proinflammatory mediators. The dicaffeoylquinic acids may be partially responsible for these anti-inflammatory properties through the inhibition of nuclear transcription factor kappa B and mitogen-activated protein kinase pathways.


Subject(s)
Asteraceae/chemistry , Inflammation/drug therapy , Leukocyte Disorders/drug therapy , Lung Diseases/drug therapy , Neutrophils/drug effects , Plant Extracts/pharmacology , Adenosine Deaminase/metabolism , Animals , Anti-Inflammatory Agents/pharmacology , Carrageenan , Disease Models, Animal , Female , Inflammation/chemically induced , Interleukin-17/metabolism , Interleukin-1beta/metabolism , Leukocyte Disorders/chemically induced , Lung/drug effects , Lung/metabolism , Lung/pathology , Lung Diseases/chemically induced , Mice , Nitrates/chemistry , Nitrites/chemistry , Peroxidase/metabolism , Phosphorylation , Pleurisy/drug therapy , Quinic Acid/analogs & derivatives , Quinic Acid/chemistry , Transcription Factor RelA/metabolism , Tumor Necrosis Factor-alpha/metabolism , p38 Mitogen-Activated Protein Kinases/metabolism
4.
Biomed Pharmacother ; 111: 1399-1407, 2019 Mar.
Article in English | MEDLINE | ID: mdl-30841455

ABSTRACT

Acute Respiratory Distress Syndrome (ARDS) is an inflammatory condition with high mortality rates, and there is still no pharmacological approach with proven effectiveness. In the past few years, several imidazole small molecules have been developed to treat conditions in which inflammation plays a central role. In the present work, we hypothesize that a novel substituted fluorophenyl imidazole synthetized by our research group would present in vivo anti-inflammatory effect in an ARDS murine model induced by LPS. Results shows that the fluorophenyl imidazole has the ability to inhibit leukocyte migration to the bronchoalveolar lavage fluid and lung tissue of animals challenged intranasally with LPS. Furthermore, this inhibition is followed with reduction in myeloperoxidase activity, nitric oxide metabolites generation and cytokines (TNF-α, IL-6, IL-17, IFN-γ and IL-10) secretion. This effect is at least partly related to the capacity of the fluorophenyl imidazole in inhibit p38 MAPK and NF-κB phosphorylation. Finally, fluorophenyl imidazole showed no signs of acute oral toxicity in the toxicological protocol suggested by OECD 423. Taken together, the results shows that fluorophenyl imidazole is a promising prototype for the development of a novel anti-inflammatory drug in which p38 MAPK and NF-κB plays a pivotal role.


Subject(s)
Anti-Inflammatory Agents/pharmacology , Imidazoles/pharmacology , Inflammation/drug therapy , Animals , Bronchoalveolar Lavage Fluid/chemistry , Cytokines/metabolism , Inflammation/metabolism , Inflammation Mediators/pharmacology , Lipopolysaccharides/pharmacology , Lung/drug effects , Lung/metabolism , Male , Mice , Nitric Oxide/metabolism , Phosphorylation/drug effects , Respiratory Distress Syndrome , p38 Mitogen-Activated Protein Kinases/metabolism
5.
J Ethnopharmacol ; 194: 337-347, 2016 Dec 24.
Article in English | MEDLINE | ID: mdl-27596330

ABSTRACT

ETHNOPHARMACOLOGICAL RELEVANCE: Ageratum conyzoides Linn (Asteraceae), a tropical plant that is very common in West Africa and some parts of Asia and South America, has been used to treat inflammatory disorders. In Brazil, teas made from A. conyzoides L. are used as anti-inflammatory, analgesic and anti-diarrheic agents. Therefore, it is necessary to study the mechanism of anti-inflammatory action of A. conyzoides L. to support its medicinal use for treating inflammatory conditions. These studies will also support the development of effective pharmacological agents with potent anti-inflammatory properties. AIM OF THE STUDY: To evaluate the anti-inflammatory effects of the crude extract (CE), its derived fractions: ethanol (EtOH-F), hexane (HEX-F), ethyl acetate (EtOAc-F) and dichloromethane (DCM-F) and isolated compounds, such as 5'-methoxy nobiletin (MeONOB), 1,2-benzopyrone and eupalestin, which are obtained from the aerial parts of A. conyzoides L. MATERIALS AND METHODS: These evaluations were performed using an animal model of inflammation induced by carrageenan. The following inflammatory parameters were analysed: leukocyte influx, protein concentration of the exudate, myeloperoxidase (MPO), adenosine deaminase (ADA) and nitric oxide metabolites (NOx) concentrations, interleukin 10 (IL-10), interleukin 17A (IL-17A), interleukin 6 (IL-6), tumor necrosis factor (TNF), interferon gamma (IFN-γ) and phosphorylation of p65 subunit of NF-κB (p-p65 NF-κB), p38 mitogen-activated protein kinases (p-p38 MAPK) were also analysed. RESULTS: CE, its EtOH-F, HEX-F, EtOAc-F and DCM-F and the isolated compounds, including MeONOB, 1,2-benzopyrone and eupalestin, significantly reduced leukocyte influx, protein concentration of the exudate, MPO, ADA, and NOx concentrations (p<0.05). CE, EtOH-F and isolated compounds significantly reduced IL-17A, IL-6, TNF and IFN-γ levels (p<0.05). CE, EtOH-F and isolated compound 1,2-benzopyrone also increased IL-10 levels (p<0.05). Isolated compounds, MeONOB, 1,2-benzopyrone and eupalestin, reduced p-p65 NF-κB and p-p38 MAPK (p<0.01). CONCLUSIONS: This study demonstrates that A. conyzoides L. exerts its important anti-inflammatory properties by inhibiting leukocyte influx and protein concentration of the exudate, as well as reducing the levels of several pro-inflammatory mediators. The anti-inflammatory action of A. conyzoides L. may be because of the inhibition of p65 NF-κB and MAPK activation by the isolated compounds.


Subject(s)
Ageratum/chemistry , Anti-Inflammatory Agents/pharmacology , Carrageenan/toxicity , Inflammation/prevention & control , Plant Extracts/pharmacology , Pleural Cavity/drug effects , Animals , Chromatography, Liquid , Inflammation/chemically induced , Male , Mice , Spectrometry, Mass, Electrospray Ionization
6.
Data Brief ; 8: 295-9, 2016 Sep.
Article in English | MEDLINE | ID: mdl-27331104

ABSTRACT

Ilex paraguariensis A. St. Hil. is a native plant of South America widely consumed as beverages for its ethno pharmacological properties, such as antioxidant, anti-inflammatory, hypocholesterolemic as well as its benefits on the cardiovascular system. Since these properties are related to its chemical composition, the identification and quantification of the major compounds of I. paraguariensis extracts still remains relevant. The data described in this article supports previous results on the anti-inflammatory effect of I. paraguariensis A. St. Hil (Mate), "The anti-inflammatory effect of I. paraguariensis A. St. Hil (Mate) in a murine model of pleurisy" [1]. The present data article reports on nine major compounds identified in I. paraguariensis extracts and its related fractions by using UPLC-PDA and UPLC-QTOF. Identification of the constituents was based on their retention times, UV absorption spectra and mass spectra data, as well as by comparison with authentic samples. The validated parameters show that the quantification by UPLC-PDA methodology developed is sensitive, precise and accurate.

7.
Int Immunopharmacol ; 36: 165-172, 2016 Jul.
Article in English | MEDLINE | ID: mdl-27155392

ABSTRACT

Ilex paraguariensis is a native plant from Southern America, where it is used as a beverage. In traditional medicine, it is used to treat many diseases including inflammation. However, we do not yet know precisely how this effect occurs. We therefore evaluated its anti-inflammatory effect in a murine model of pleurisy. The standardized CE, BF and ARF fractions, Caf, Rut and CGA were able to reduce leukocyte migration, exudate concentration, MPO and ADA activities and NOx levels. Moreover, I. paraguariensis also inhibited the release of Th1/Th17 pro-inflammatory cytokines, while increasing IL-10 production and improving the histological architecture of inflamed lungs. In addition, its major compounds decreased p65 NF-κB phosphorylation. Based on our results, we can conclude that I. paraguariensis exerts its anti-inflammatory action by attenuating the Th1/Th17 polarization in this model. This fact suggests that the use of this plant as a beverage can protect against Th1/Th17 inflammatory diseases.


Subject(s)
Anti-Inflammatory Agents/therapeutic use , Ilex paraguariensis/immunology , Leukocytes/drug effects , Medicine, Traditional , Plant Extracts/therapeutic use , Pleurisy/drug therapy , Animals , Caffeine/chemistry , Caffeine/therapeutic use , Cell Movement/drug effects , Chlorogenic Acid/chemistry , Chlorogenic Acid/therapeutic use , Disease Models, Animal , Female , Humans , Interleukin-10/metabolism , Leukocytes/physiology , Mice , NF-kappa B/metabolism , Oxidative Stress/drug effects , Plant Extracts/chemistry , Rutin/chemistry , Rutin/therapeutic use , South America , Th1 Cells/immunology , Th17 Cells/immunology
8.
Planta Med ; 79(17): 1605-14, 2013 Nov.
Article in English | MEDLINE | ID: mdl-24288274

ABSTRACT

Rosmarinus officinalis, also named rosemary, is a native plant from the Mediterranean region that is useful for the treatment of inflammatory diseases. Studies using experimental models and/or in vitro tests have shown the important biological effects of rosemary. In this context, the mechanism of the anti-inflammatory activity of rosemary must be investigated to support the discovery of new substances with anti-inflammatory effects. The aim of the present study was to investigate the anti-inflammatory effects of crude extract oil free obtained from the leaves of rosemary in an animal model of inflammation, thus evaluating its medicinal use for the treatment of inflammatory conditions. Also its ethanol, hexane, and ethyl acetate fractions, as well as its isolated compounds carnosol and rosmarinic acid were analyzed. Swiss mice were used for the in vivo experiments. The effect of this herb on the inhibition of the leukocytes, exudation, myeloperoxidase, and adenosine-deaminase activities, nitrite/nitrate, interleukin 17A, and interleukin 10 levels and mRNA expression was determined. The crude extract and its derived fractions, in addition to its isolated compounds, inhibited leukocytes and decreased exudation and myeloperoxidase and adenosine-deaminase activities, as well as nitrite/nitrate and interleukin 17A levels and mRNA expression, besides increasing interleukin 10 levels and mRNA expression. Rosemary showed important anti-inflammatory activity by inhibiting leukocytes and decreasing exudation. These effects were associated with a decrease in the proinflammatory parameters (myeloperoxidase, adenosine-deaminase, nitrite/nitrate, and interleukin 17A) and an increase in the anti-inflammatory cytokine (interleukin 10). This study confirms the anti-inflammatory properties of rosemary and validates its use in folk medicine to treat inflammatory diseases such as rheumatism and asthma.


Subject(s)
Anti-Inflammatory Agents/therapeutic use , Inflammation Mediators/metabolism , Inflammation/drug therapy , Phytotherapy , Plant Extracts/therapeutic use , Pleurisy/drug therapy , Rosmarinus/chemistry , Abietanes/isolation & purification , Abietanes/pharmacology , Abietanes/therapeutic use , Adenosine Deaminase/metabolism , Animals , Anti-Inflammatory Agents/pharmacology , Carrageenan , Cinnamates/isolation & purification , Cinnamates/pharmacology , Cinnamates/therapeutic use , Cytokines/genetics , Cytokines/metabolism , Depsides/isolation & purification , Depsides/pharmacology , Depsides/therapeutic use , Disease Models, Animal , Inflammation/chemically induced , Inflammation/genetics , Inflammation/metabolism , Leukocytes/metabolism , Mice , Mice, Inbred Strains , Nitrates/metabolism , Nitrites/metabolism , Peroxidase/metabolism , Plant Extracts/chemistry , Plant Extracts/pharmacology , Plant Leaves , Pleurisy/chemically induced , Pleurisy/genetics , Pleurisy/metabolism , RNA, Messenger/metabolism , Rosmarinic Acid
SELECTION OF CITATIONS
SEARCH DETAIL
...